Treatment of acquired von willebrand syndrome in aortic stenosis with transcatheter aortic valve replacement

JACC: Cardiovascular Interventions

Volumn 8, Issue 5, 2015, Pages 692-700

  Spangenberg, Tobias ^a   Budde, Ulrich ^b   Schewel, Dimitry ^a   Frerker, Christian ^a   Thielsen, Thomas ^a   Kuck, Karl Heinz ^a   Schäfer, Ulrich ^a,c  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

^b Medilys Laborgesellschaft mbH   (Germany)

^c UNIVERSITY HEART CENTER HAMBURG   (Germany)

Author keywords

aortic stenosis; transcatheter aortic valve replacement; von Willebrand syndrome

Indexed keywords

AGED; AORTA VALVE REGURGITATION; AORTA VALVE STENOSIS; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; HEART HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS AORTIC VALVE; POSTOPERATIVE COMPLICATION; PRESSURE GRADIENT; PREVALENCE; PRIORITY JOURNAL; PROSTHESIS PATIENT MISMATCH; STATISTICS; SWAN GANZ CATHETER; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VON WILLEBRAND DISEASE; ADVERSE EFFECTS; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; BLOOD; DEVICES; GERMANY; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; PATHOPHYSIOLOGY; PROCEDURES; REGISTER; RISK FACTOR; TIME FACTOR; VERY ELDERLY; VON WILLEBRAND DISEASES;

AGED; AGED, 80 AND OVER; AORTIC VALVE INSUFFICIENCY; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; FEMALE; GERMANY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MALE; PREVALENCE; REGISTRIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VON WILLEBRAND DISEASES;

EID: 84929168398     PISSN: 19368798     EISSN: 18767605     Source Type: Journal    
DOI: 10.1016/j.jcin.2015.02.008     Document Type: Article

References (32)

1. T.E. Warkentin, J.C. Moore, S.S. Anand, E.M. Lonn, and D.G. Morgan Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome Transfus Med Rev 17 2003 272 286
2. T.E. Warkentin, J.C. Moore, and D.G. Morgan Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand's disease the link? Lancet 340 1992 35 37
3. E. Heyde Gastrointestinal bleeding in aortic stenosis N Engl J Med 259 1958
4. T. Le Tourneau, S. Susen, and C. Caron Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction Circulation 118 2008 1550 1557
5. S. Panzer, R. Badr Eslam, and A. Schneller Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis Thromb Haemost 103 2010 408 414
6. A. Vincentelli, S. Susen, and T. Le Tourneau Acquired von Willebrand syndrome in aortic stenosis N Engl J Med 349 2003 343 349
7. J.L. Thompson 3rd, H.V. Schaff, and J.A. Dearani Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome J Thorac Cardiovasc Surg 144 2012 112 116
8. C.R. Smith, M.B. Leon, and M.J. Mack Transcatheter versus surgical aortic-valve replacement in high-risk patients N Engl J Med 364 2011 2187 2198
9. D.H. Adams, J.J. Popma, and M.J. Reardon Transcatheter aortic-valve replacement with a self-expanding prosthesis N Engl J Med 370 2014 1790 1798
10. D.R. Lynch Jr., D. Dantzler, M. Robbins, and D. Zhao Considerations in antithrombotic therapy among patients undergoing transcatheter aortic valve implantation J Thromb Thrombolysis 35 2013 476 482
11. H.B. Ribeiro, M. Urena, K.H. Kuck, J.G. Webb, and J. Rodes-Cabau Edwards CENTERA valve EuroIntervention 8 Suppl Q 2012 Q79 Q82
12. R.K. Binder, U. Schafer, and K.H. Kuck Transcatheter aortic valve replacement with a new self-expanding transcatheter heart valve and motorized delivery system J Am Coll Cardiol Intv 6 2013 301 307
13. E. Grube, G. Schuler, and L. Buellesfeld Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome J Am Coll Cardiol 50 2007 69 76
14. J.G. Webb, M. Chandavimol, and C.R. Thompson Percutaneous aortic valve implantation retrograde from the femoral artery Circulation 113 2006 842 850
15. J.B. Chambers, D.C. Sprigings, and T. Cochrane Continuity equation and Gorlin formula compared with directly observed orifice area in native and prosthetic aortic valves Br Heart J 67 1992 193 199
16. R. Gorlin, and S.G. Gorlin Hydraulic formula for calculation of the area of the stenotic mitral valve, other cardiac valves, and central circulatory shunts. I Am Heart J 41 1951 1 29
17. D. Chemla, J.L. Hebert, and C. Coirault Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans Am J Physiol 274 1998 H500 H505
18. A.P. Kappetein, S.J. Head, and P. Genereux Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document J Thorac Cardiovasc Surg 145 2013 6 23
19. C.A. Lee, A. Hubbard, and C.A. Sabin Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas J Thromb Haemost 9 2011 220 222
20. S. Lippok, T. Obser, and J.P. Muller Exponential size distribution of von Willebrand factor Biophys J 105 2013 1208 1216
21. J. Cejka Enzyme immunoassay for factor VIII-related antigen Clin Chem 28 1982 1356 1358
22. S.H. Rahimtoola The problem of valve prosthesis-patient mismatch Circulation 58 1978 20 24
23. P. Pibarot, and J.G. Dumesnil Prosthesis-patient mismatch: definition, clinical impact, and prevention Heart 92 2006 1022 1029
24. U. Budde, R. Schneppenheim, and J. Eikenboom Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD) J Thromb Haemost 6 2008 762 771
25. C. Sucker, P. Feindt, R.B. Zotz, M. Stockschlaeder, and R.E. Scharf Functional von Willebrand Factor assays are not predictive for the absence of highest-molecular weight von Willebrand Factor multimers in patients with aortic-valve stenosis Thromb Haemost 94 2005 465 466
26. R.M. King, J.R. Pluth, and E.R. Giuliani The association of unexplained gastrointestinal bleeding with calcific aortic stenosis Ann Thorac Surg 44 1987 514 516
27. J.L. Blackshear, E.M. Wysokinska, and R.E. Safford Indexes of von Willebrand factor as biomarkers of aortic stenosis severity (from the Biomarkers of Aortic Stenosis Severity [BASS] study) Am J Cardiol 111 2013 374 381
28. S.K. Kodali, M.R. Williams, and C.R. Smith Two-year outcomes after transcatheter or surgical aortic-valve replacement N Engl J Med 366 2012 1686 1695
29. P. Lancellotti, E. Donal, and J. Magne Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay Heart 96 2010 1364 1371
30. D.W. Yaffee, D.E. Smith 3rd, and P.A. Ursomanno Management of blood transfusion in aortic valve surgery: impact of a blood conservation strategy Ann Thorac Surg 97 2014 95 101
31. C. Heilmann, U. Geisen, and F. Beyersdorf Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS) Intensive Care Med 38 2012 62 68
32. J.M. Sinning, C. Hammerstingl, and M. Vasa-Nicotera Aortic regurgitation index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation J Am Coll Cardiol 59 2012 1134 1141